Clincosm LogoSign in Get a demo

Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

Sponsor
Bispebjerg Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00483145
Collaborator
(none)
1
Location
2
Arms
12
Duration (Months)

Study Details

Study Description

Brief Summary

To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.

Condition or Disease Intervention/Treatment Phase
  • Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)
  • Device: Long-pulsed dye laser
  • Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
 N/A

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single
Official Title:
Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea
Study Start Date :
Nov 1, 2006
Actual Study Completion Date :
Nov 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

Long-pulsed dye laser (Candela)

Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)

Device: Long-pulsed dye laser
Active Comparator: 2

Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)

Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)

Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • Inflammatory acne and rosacea

    • Skin types I-IV

    Exclusion Criteria:

    • Patients younger than 18 years

    • Skin types V and VI

    • Topical and systemic conventional acne treatments

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Bispebjerg Hospital Copenhagen NV Denmark 2400

    Sponsors and Collaborators

    • Bispebjerg Hospital

    Investigators

    • Principal Investigator: Merete Hædersdal, Bispebjerg Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00483145
    Other Study ID Numbers:
    • KF-01-328309
    First Posted:
    Jun 6, 2007
    Last Update Posted:
    Jun 3, 2008
    Last Verified:
    Jun 1, 2008
    Additional relevant MeSH terms:
    Acne Vulgaris
    Rosacea
    Methyl 5-aminolevulinate
    Aminolevulinic Acid

    Study Results

    No Results Posted as of Jun 3, 2008